ResearcherScience for Life LaboratoryNo recent work listed

Lena Claesson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4275-2000; OpenAlex author ID A5082204429. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival. Last author DOI 10.1002/path.5141 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vegard Tjomsland · 1 shared paper, 2018 · strength 0.08
- Paper VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of… DOI 10.1002/path.5141 ↗
Eric Morin · 1 shared paper, 2018 · strength 0.08
- Paper VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of… DOI 10.1002/path.5141 ↗
Oskar Franklin · 1 shared paper, 2018 · strength 0.08
- Paper VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of… DOI 10.1002/path.5141 ↗
Malin Sund · 1 shared paper, 2018 · strength 0.08
- Paper VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of… DOI 10.1002/path.5141 ↗
Daniel Öhlund · 1 shared paper, 2018 · strength 0.08
- Paper VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of… DOI 10.1002/path.5141 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.